Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients

Aim: To evaluate the efficacy ofthe application of various chemotherapy schemes based on the immunohistochemical study of expression
 patterns of proteins associated with the drug resistance P-glycoprotein (P-gp), glutathione-S-transferase (GST), metallothioneins
 (МТ) of breast canc...

Full description

Saved in:
Bibliographic Details
Published in:Experimental Oncology
Date:2009
Main Authors: Chekhun, V.F., Zhylchuk, V.E., Lukyanova, N.Yu., Vorontsova, A.L., Kudryavets, Yu.I.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2009
Subjects:
Online Access:https://nasplib.isofts.kiev.ua/handle/123456789/135725
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients / V.F. Chekhun, V.E. Zhylchuk, N.Yu. Lukyanova, A.L. Vorontsova, Yu.I. Kudryavets // Experimental Oncology. — 2009. — Т. 31, № 2. — С. 123–124. — назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
_version_ 1862751364551016448
author Chekhun, V.F.
Zhylchuk, V.E.
Lukyanova, N.Yu.
Vorontsova, A.L.
Kudryavets, Yu.I.
author_facet Chekhun, V.F.
Zhylchuk, V.E.
Lukyanova, N.Yu.
Vorontsova, A.L.
Kudryavets, Yu.I.
citation_txt Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients / V.F. Chekhun, V.E. Zhylchuk, N.Yu. Lukyanova, A.L. Vorontsova, Yu.I. Kudryavets // Experimental Oncology. — 2009. — Т. 31, № 2. — С. 123–124. — назв. — англ.
collection DSpace DC
container_title Experimental Oncology
description Aim: To evaluate the efficacy ofthe application of various chemotherapy schemes based on the immunohistochemical study of expression
 patterns of proteins associated with the drug resistance P-glycoprotein (P-gp), glutathione-S-transferase (GST), metallothioneins
 (МТ) of breast cancer (BC) patients with the triple-receptor-negative (RE–, RP–, HER-2/neu–) cancer. Methods and Results: P-gp,
 GST and МТ expression in BC-biopsy samples from 60 BC patients was evaluated by immunohistochemical analysis. The results
 of the clinical observations showed that 3-years relapse-free survival rate of the patients of with P-gp, GST and МТ-positive tumors
 treated with taxoter + adriablastin / taxoter + cyclophosphamide (ТА/ТС), gemcitabine + carboplatin, or TC + bevacizumab was
 61.5%, 78.6% and 81.2% respectively, vs 41.2% in the control group with P-gp, GST and МТ-negative tumors treated with adriablastin
 + cyclophosphamide (p < 0.05), while overall survival rates were 84.4%, 92.6% and 93.8% respectively vs 70.6% in the control
 group (p < 0.05). Conclusion: The study points on the possibility to elevate the efficiency of polychemotherapy by its individualization
 based on the expression patterns of Р-gp, GST and MT on tumor cells of the patients with the triple-receptor-negative BC.
first_indexed 2025-12-07T21:11:17Z
format Article
fulltext
id nasplib_isofts_kiev_ua-123456789-135725
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
issn 1812-9269
language English
last_indexed 2025-12-07T21:11:17Z
publishDate 2009
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
record_format dspace
spelling Chekhun, V.F.
Zhylchuk, V.E.
Lukyanova, N.Yu.
Vorontsova, A.L.
Kudryavets, Yu.I.
2018-06-15T14:21:07Z
2018-06-15T14:21:07Z
2009
Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients / V.F. Chekhun, V.E. Zhylchuk, N.Yu. Lukyanova, A.L. Vorontsova, Yu.I. Kudryavets // Experimental Oncology. — 2009. — Т. 31, № 2. — С. 123–124. — назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/135725
Aim: To evaluate the efficacy ofthe application of various chemotherapy schemes based on the immunohistochemical study of expression
 patterns of proteins associated with the drug resistance P-glycoprotein (P-gp), glutathione-S-transferase (GST), metallothioneins
 (МТ) of breast cancer (BC) patients with the triple-receptor-negative (RE–, RP–, HER-2/neu–) cancer. Methods and Results: P-gp,
 GST and МТ expression in BC-biopsy samples from 60 BC patients was evaluated by immunohistochemical analysis. The results
 of the clinical observations showed that 3-years relapse-free survival rate of the patients of with P-gp, GST and МТ-positive tumors
 treated with taxoter + adriablastin / taxoter + cyclophosphamide (ТА/ТС), gemcitabine + carboplatin, or TC + bevacizumab was
 61.5%, 78.6% and 81.2% respectively, vs 41.2% in the control group with P-gp, GST and МТ-negative tumors treated with adriablastin
 + cyclophosphamide (p < 0.05), while overall survival rates were 84.4%, 92.6% and 93.8% respectively vs 70.6% in the control
 group (p < 0.05). Conclusion: The study points on the possibility to elevate the efficiency of polychemotherapy by its individualization
 based on the expression patterns of Р-gp, GST and MT on tumor cells of the patients with the triple-receptor-negative BC.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Short communications
Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
Article
published earlier
spellingShingle Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
Chekhun, V.F.
Zhylchuk, V.E.
Lukyanova, N.Yu.
Vorontsova, A.L.
Kudryavets, Yu.I.
Short communications
title Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
title_full Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
title_fullStr Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
title_full_unstemmed Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
title_short Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
title_sort expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
topic Short communications
topic_facet Short communications
url https://nasplib.isofts.kiev.ua/handle/123456789/135725
work_keys_str_mv AT chekhunvf expressionofdrugresistanceproteinsintriplereceptornegativetumorsasthebasisofindividualizedtherapyofthebreastcancerpatients
AT zhylchukve expressionofdrugresistanceproteinsintriplereceptornegativetumorsasthebasisofindividualizedtherapyofthebreastcancerpatients
AT lukyanovanyu expressionofdrugresistanceproteinsintriplereceptornegativetumorsasthebasisofindividualizedtherapyofthebreastcancerpatients
AT vorontsovaal expressionofdrugresistanceproteinsintriplereceptornegativetumorsasthebasisofindividualizedtherapyofthebreastcancerpatients
AT kudryavetsyui expressionofdrugresistanceproteinsintriplereceptornegativetumorsasthebasisofindividualizedtherapyofthebreastcancerpatients